104 related articles for article (PubMed ID: 11578300)
1. Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1.
Langer P; Wild A; Celik I; Kopp I; Bergenfelz A; Bartsch DK
Br J Surg; 2001 Oct; 88(10):1403-7. PubMed ID: 11578300
[TBL] [Abstract][Full Text] [Related]
2. Prospective screening in multiple endocrine neoplasia type 1.
Skogseid B; Oberg K
Henry Ford Hosp Med J; 1992; 40(3-4):167-70. PubMed ID: 1362398
[TBL] [Abstract][Full Text] [Related]
3. A meal stimulation test in the diagnosis of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
Migliori M; Tomassetti P; Campana D; Boschi S; Pezzilli R; Piscitelli L; Corinaldesi R; Gullo L
Endocrine; 2002 Apr; 17(3):229-32. PubMed ID: 12108524
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
[TBL] [Abstract][Full Text] [Related]
5. The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1.
Oberg K; Skogseid B
J Intern Med; 1998 Jun; 243(6):471-6. PubMed ID: 9681845
[TBL] [Abstract][Full Text] [Related]
6. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
[TBL] [Abstract][Full Text] [Related]
7. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?
Bartsch DK; Langer P; Wild A; Schilling T; Celik I; Rothmund M; Nies C
Surgery; 2000 Dec; 128(6):958-66. PubMed ID: 11114630
[TBL] [Abstract][Full Text] [Related]
8. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic-polypeptide (PP) and endocrine tumours of the pancreas.
Schwartz TW
Scand J Gastroenterol Suppl; 1979; 53():93-100. PubMed ID: 225793
[TBL] [Abstract][Full Text] [Related]
10. [Abnormal increase in pancreatic polypeptide in the secretin-provocation test: hypoglycemia-induced?].
Wirth HP; Eberle C; Gautschi K; Meyenberger C; Ammann R
Schweiz Med Wochenschr; 1995 Apr; 125(15):735-9. PubMed ID: 7740287
[TBL] [Abstract][Full Text] [Related]
11. Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours.
Nehar D; Lombard-Bohas C; Olivieri S; Claustrat B; Chayvialle JA; Penes MC; Sassolas G; Borson-Chazot F
Clin Endocrinol (Oxf); 2004 May; 60(5):644-52. PubMed ID: 15104570
[TBL] [Abstract][Full Text] [Related]
12. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Przegl Lek; 1995; 52(12):590-3. PubMed ID: 8834657
[TBL] [Abstract][Full Text] [Related]
13. A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience.
Skogseid B; Oberg K; Benson L; Lindgren PG; Lörelius LE; Lundquist G; Wide L; Wilander E
J Clin Endocrinol Metab; 1987 Jun; 64(6):1233-40. PubMed ID: 2883195
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.
McCallum RW; Parameswaran V; Burgess JR
Clin Endocrinol (Oxf); 2006 Aug; 65(2):163-8. PubMed ID: 16886955
[TBL] [Abstract][Full Text] [Related]
15. [Multiple endocrine neoplasia type 1: genetic and clinical aspects].
Calender A; Cadiot G; Mignon M
Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B38-48. PubMed ID: 11449144
[No Abstract] [Full Text] [Related]
16. Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Langer P; Kann PH; Fendrich V; Richter G; Diehl S; Rothmund M; Bartsch DK
World J Surg; 2004 Dec; 28(12):1317-22. PubMed ID: 15517479
[TBL] [Abstract][Full Text] [Related]
17. Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1). Implications for an integrated model of MEN-1 tumorigenesis.
Burgess JR; Greenaway TM; Parameswaran V; Shepherd JJ
Cancer; 1999 Nov; 86(10):2154-9. PubMed ID: 10570446
[TBL] [Abstract][Full Text] [Related]
18. Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms.
Gauger PG; Doherty GM; Broome JT; Miller BS; Thompson NW
Surgery; 2009 Oct; 146(4):801-6; discussion 807-8. PubMed ID: 19789041
[TBL] [Abstract][Full Text] [Related]
19. Is pancreatic polypeptide response to food ingestion a reliable index of vagal function in type 1 diabetes?
Damholt MB; Arlien-Soeborg P; Hilsted L; Hilsted J
Scand J Clin Lab Invest; 2006; 66(4):279-86. PubMed ID: 16777756
[TBL] [Abstract][Full Text] [Related]
20. Basal and postatropine serum pancreatic polypeptide concentrations in familial multiple endocrine neoplasia type I.
Lamers CB; Diemel CM
J Clin Endocrinol Metab; 1982 Oct; 55(4):774-8. PubMed ID: 7107820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
